Hyposafe SubQ is a project dedicated to the prevention of severe hypoglycemia. The human brain, which lives primarily on glucose, begins to demonstrate recognisable electric patterns approximately 20 minutes before hypoglycemia. By continuously measuring the electrical activity within the brain, hypoglycemia can be detected, and people with diabetes get alerted before the situation becomes critical. When alerted, the patient can take the necessary action required to avoid hypoglycemia and thereafter adjust his/her glucose level to the appropriate interval.
The hyposafe SubQ technology allows to monitor your brain activity continuously. The challenge is to create a product that is only minimally obstructive as it has to be worn continuously. When designing the external device we had to make sure that the product is as invisible as possible, yet still able to interact with the user, especially when an alarm occurs. Being used 24 hours, the reliability of the product is of extreme importance.
Achilles Design took the lead in the mechanical design & engineering of the external device in close collaboration with Zenso who was responsible for the overall design of the external communication device and designed all the electronics, firmware and PC-based software from feasibility phase up to design and production. Focus on superior quality and reliability was key to achieve the Uneeg quality requirements.
The product consists of a tiny implant and an external communication device that is connected with the implant through an inductive coil. The final design of the external device is a highly miniaturized flat product that can be magnetically fixed below the patient’s clothes. The magnet has a circle shape allowing the patient to blindly find their way to the button positioned on the inside of his shirt. The optimized magnet will ensure a strong fixation allowing the user to be very active, perform sport etc. An auditory and visual alarm is given in case of a nearing hypoglycemia.
The Unique Uneeg technology can be used to treat other diseases. Identifying the seizure burden for the uncontrolled epilepsy patient. Getting an objective measure of the individual patient’s epileptic seizure burden can be a challenge for the treating physician and it is crucial for guiding treatment. The UNEEG 24/7 EEGTM SubQ will offer medical professionals more accurate knowledge of brain activity and seizure – 24 hours a day.
The Danish company Uneeg succeeded to develop a disruptive system for ultra long-term monitoring EEG. The UNEEG 24/7 EEGTM SubQ is CE marked and ready to offer medical professionals more accurate knowledge of brain activity and seizures. Thereby, physicians gain a solid foundation for optimizeing the use of medicine, thus improving the patients’ quality of life and potentially avoiding seizures altogether.